5044-10-0

Basic information

• Product Name: 11a,13a-dimethyl-3,4,4a,4b,5,6,9,10,11,11a,11b,12,13,13a-tetradecahydro-1H-quino[6,5-g][3]benzazepine-2,8-dione
• CAS NO: 5044-10-0
• Molecular Formula: C₁₉H₂₈N₂O₂
• Molecular Weight: 316.4378
• Mol File: 5044-10-0.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 572.4°C at 760 mmHg
• Flash Point: 206.2°C
• Density: 1.16g/cm³
• Vapor Pressure: 4.14E-13mmHg at 25°C
• Refractive Index: 1.57
• CAS DataBase Reference: 11a,13a-dimethyl-3,4,4a,4b,5,6,9,10,11,11a,11b,12,13,13a-tetradecahydro-1H-quino[6,5-g][3]benzazepine-2,8-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 11a,13a-dimethyl-3,4,4a,4b,5,6,9,10,11,11a,11b,12,13,13a-tetradecahydro-1H-quino[6,5-g][3]benzazepine-2,8-dione(5044-10-0)
• EPA Substance Registry System: 11a,13a-dimethyl-3,4,4a,4b,5,6,9,10,11,11a,11b,12,13,13a-tetradecahydro-1H-quino[6,5-g][3]benzazepine-2,8-dione(5044-10-0)

Safety Data

• Hazardous Substances Data: 5044-10-0(Hazardous Substances Data)

Usage

Quinazoline derivative

Contains a benzoquinazoline ring system.

Two dimethyl groups

These groups are attached to the 11a and 13a positions of the molecule.

Dione functional group

A carbonyl group (C=O) is present at the 2 and 8 positions of the molecule.

Multiple cyclohexane rings

The compound has several six-membered carbon rings in its structure.

Cyclic compound

The molecule forms a closed loop or ring.

Highly fused and complex structure

The compound has a complicated arrangement of its atoms and bonds.

Potential pharmaceutical or medicinal applications

Due to its unique structure and chemical properties, it may have uses in the development of drugs or medicines.

Further research and analysis needed

To determine the specific uses and effects of the compound, additional studies are required.
Please note that the information provided is based on the given material, and the compound's properties and applications may vary depending on the context and further research.

Upstream product

• 59285-18-6 17β-acetoxy-3-hydroximinoandrost-4-ene 
• 20986-87-2 3-aza-A-homo-4α-androstene-4,17-dione 
• 21058-55-9 3-aza-17β-acetoxy-A-homo-4α-androsten-4-one 
• 21058-56-0 8-hydroxy-5a,7a-dimethyl-3,4,5,5a,5b,6,7,7a,8,9,10,10a,11,12-tetradecahydrocyclopenta-[5,6]naphtho[1,2-d]azepin-2(10bH)-one 
• 1600-81-3 (10aR,12aS)-10a,12a-dimethyl-4,4a,4b,5,6,9,10,10a,10b,11,12,12a-dodecahydronaphtho[2,1-f]quinoline-2,8(1H,3H)-dione 
• 87984-69-8 (4aS,4bR,10aR,10bS,12aS)-10a,12a-Dimethyl-1,3,4,4a,4b,5,6,9,10,10a,10b,11,12,12a-tetradecahydro-1-aza-chrysene-2,8-dione 8-oxime 
• 21058-62-8 3-aza-A-homo-4α-androsten-4,17-dione oxime 

Relevant articles and documents

Beckmann rearrangement of 3-aza-A-homo-4α-androsten-4,17-dione oxime and 3-oxo-13α-amino-13,17-seco-4-androsten-17-oic 13,17-lactam oxime

Rearragements of 3-aza-A-homo-4α-androsten-4,17-dione oxime produced a mixture of the normal lactam product and the product of a 'second order' cleavage, an unsaturated nitrile. The lactam 3,17α-diaza-A,D-bishomoandrost-4α-ene-4,17-dione was also obtained from the rearrangement of the syn-3-oxo-13α-amino-13,17-seco-4-androsten-17-oic-13,17-lactam oxime. The resolution of syn- and anti-isomers of VIII was effected by column chromatography and their structure was determined by spectral data.